Ying JE - Search Results

1

Efficacy and safety of bevacizumab in Chinese patients with metastatic colorectal cancer.

Zhu LM, Zhao YZ, Ju HX, Liu LY, Chen L, Liu BX, Xu Q, Luo C, Ying JE, Yang YS, Zhong HJ. Zhu LM, et al. Among authors: ying je. Asian Pac J Cancer Prev. 2014;15(16):6559-64. doi: 10.7314/apjcp.2014.15.16.6559. Asian Pac J Cancer Prev. 2014. PMID: 25169487 Free article.

2

[Effect of Supportan on nutritional status and immune function of late-staged gastric cancer patients undergoing chemotherapy].

Zhong HJ, Ying JE, Ma SL. Zhong HJ, et al. Among authors: ying je. Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Sep;9(5):405-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 17043961 Clinical Trial. Chinese.

3

Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

Zhong H, Zhang Y, Ma S, Ying JE, Yang Y, Yong D, Hang X, Sun Q, Zhong B, Wang D. Zhong H, et al. Among authors: ying je. Anticancer Drugs. 2008 Nov;19(10):1013-8. doi: 10.1097/CAD.0b013e328314b5ab. Anticancer Drugs. 2008. PMID: 18827567

4

[Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].

Yu PF, Guo JM, Xu Q, Ying JE, Wang XJ, Cheng XD, Wang XB, Yu CD. Yu PF, et al. Among authors: ying je. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Apr;13(4):289-93. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20422488 Chinese.

5

The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.

Ying J, Xu Q, Zhang G, Liu B, Zhu L. Ying J, et al. Med Oncol. 2012 Sep;29(3):1716-22. doi: 10.1007/s12032-011-9990-0. Epub 2011 Jun 1. Med Oncol. 2012. PMID: 21630055

6

Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism.

Luo C, Zhong HJ, Zhu LM, Wu XG, Ying JE, Wang XH, Lü WX, Xu Q, Zhu YL, Huang J. Luo C, et al. Among authors: ying je. Mol Biol Rep. 2012 May;39(5):5459-64. doi: 10.1007/s11033-011-1346-5. Epub 2011 Dec 30. Mol Biol Rep. 2012. PMID: 22207169

7

S-1 combined with oxaliplatin as first line chemotherapy for Chinese advanced gastric cancer patients.

Liu B, Ying J, Luo C, Xu Q, Zhu L, Zhong H. Liu B, et al. Hepatogastroenterology. 2012 Mar-Apr;59(114):649-53. doi: 10.5754/hge11893. Hepatogastroenterology. 2012. PMID: 22328264 Clinical Trial.

8

Developments in metastatic pancreatic cancer: is gemcitabine still the standard?

Ying JE, Zhu LM, Liu BX. Ying JE, et al. World J Gastroenterol. 2012 Feb 28;18(8):736-45. doi: 10.3748/wjg.v18.i8.736. World J Gastroenterol. 2012. PMID: 22371633 Free PMC article. Review.

9

The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis.

Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H. Ying J, et al. Onco Targets Ther. 2015 Sep 1;8:2427-33. doi: 10.2147/OTT.S88592. eCollection 2015. Onco Targets Ther. 2015. PMID: 26366097 Free PMC article.

10

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.

He Q, Xu Q, Wu W, Chen L, Sun W, Ying J. He Q, et al. Onco Targets Ther. 2016 Apr 20;9:2329-35. doi: 10.2147/OTT.S97668. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters